Significant increase of esophageal mucin secretion in patients with reflux esophagitis after healing with rabeprazole: Its esophagoprotective potential

Digestive Diseases and Sciences

Volumn 54, Issue 10, 2009, Pages 2137-2142

  Sarosiek, Irene ^a   Olyaee, Mojtaba ^a   Majewski, Marek ^b   Sidorenko, Elena ^a   Roeser, Katherine ^a   Sostarich, Sandra ^a   Wallner, Grzegorz ^b   Sarosiek, Jerzy ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Esophageal mucin secretion; Healing of reflux esophagitis; Rabeprazole

Indexed keywords

HYDROCHLORIC ACID; MUCIN; PEPSIN A; RABEPRAZOLE; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; CATHETER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ESOPHAGUS MUCOSA; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REFLUX ESOPHAGITIS; TREATMENT DURATION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AGED; ANTI-ULCER AGENTS; ESOPHAGITIS, PEPTIC; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCINS;

EID: 70149101107     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0589-z     Document Type: Article

References (26)

1. J Sarosiek RW [tmp] McCallum 2000 Mechanisms of oesophageal mucosal defense Best Pract Res Clin Gastroenterol 14 701 717 10.1053/bega.2000.0119 PMID: 11003804 (Pubitemid 30791843)
2. J Sarosiek RT Jensen PN Maton, et al. 2000 Salivary and gastric epidermal growth factor in patients with Zollinger-Ellison syndrome: its protective potential Am J Gastroenterol 95 1158 1165 10.1111/j.1572-0241.2000.02003.x PMID: 10811321
3. M Marcinkiewicz Z Namiot MC Edmunds RW [tmp] McCallum J Sarosiek 1996 Detrimental impact of acid and pepsin on the rate of luminal release of transforming growth factor alpha. Its potential pathogenetic role in the development of reflux esophagitis J Clin Gastroenterol 23 261 268 10.1097/00004836-199612000-00005 PMID: 8957727 (Pubitemid 26422090)
4. J Sarosiek CJ Scheurich M Marcinkiewicz RW [tmp] McCallum 1996 Enhancement of salivary esophagoprotection: rationale for a physiological approach to gastroesophageal reflux disease Gastroenterology 110 675 681 10.1053/gast.1996.v110.pm8608875 see comment. PMID: 8608875 (Pubitemid 26071835)
5. Z Namiot J Sarosiek RM Rourk DP Hetzel RW [tmp] McCallum 1994 Human esophageal secretion: mucosal response to luminal acid and pepsin Gastroenterology 106 973 981 PMID: 8144002 (Pubitemid 24109283)
6. MF Vaezi S Singh JE Richter 1995 Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies Gastroenterology 108 1897 1907 10.1016/0016-5085(95)90156-6 PMID: 7768397
7. LB Gerson V Boparai N Ullah G Triadafilopoulos 2004 Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors Aliment Pharmacol Ther 20 637 643 10.1111/j.1365-2036.2004.02127.x PMID: 15352912 (Pubitemid 39279052)
8. RE Marshall A Anggiansah DK Manifold WA Owen WJ Owen 1998 Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus Gut 43 603 606 PMID: 9824338
9. AI Sarela DG Hick CS Verbeke JF Casey PJ Guillou GW Clark 2004 Persistent acid and bile reflux in asymptomatic patients with Barrett esophagus receiving proton pump inhibitor therapy Arch Surg 139 547 551 10.1001/archsurg.139.5.547 PMID: 15136356 (Pubitemid 38585755)
10. R Fass M Shapiro R Dekel J Sewell 2005 Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease-where next? Aliment Pharmacol Ther 22 79 94 10.1111/j.1365-2036.2005.02531.x PMID: 16011666
11. J Sarosiek RW [tmp] McCallum 1995 What is the secretory potential of submucosal mucous glands within the human gullet in health and disease? Digestion 56 1 15 23 PMID: 7556966
12. Z Namiot ZJ Yu R Piascik DP Hetzel RW [tmp] McCallum J Sarosiek 1997 Modulatory effect of esophageal intraluminal mechanical and chemical stressors on salivary prostaglandin E2 in humans Am J Med Sci 313 90 98 10.1097/00000441-199702000-00004 PMID: 9030674 (Pubitemid 27089860)
13. M Marcinkiewicz J Sarosiek M Edmunds J Scheurich P Weiss RW [tmp] McCallum 1995 Monophasic luminal release of prostaglandin E2 in patients with reflux esophagitis under the impact of acid and acid/pepsin solutions. Its potential pathogenetic significance J Clin Gastroenterol 21 268 274 10.1097/00004836-199512000-00003 PMID: 8583097
14. J Sarosiek RW [tmp] McCallum 1995 Do salivary organic components play a protective role in health and disease of the esophageal mucosa? Digestion 56 1 32 37 PMID: 7556968
15. J Sarosiek RW [tmp] McCallum 1995 What role do salivary inorganic components play in health and disease of the esophageal mucosa? Digestion 56 1 24 31 PMID: 7556967
16. M Majewski T Jaworski I Sarosiek, et al. 2007 Significant enhancement of esophageal pre-epithelial defense by tegaserod: implications for an esophagoprotective effect Clin Gastroenterol Hepatol 5 430 438 10.1016/j.cgh.2007.01.002 PMID: 17445751 (Pubitemid 46584835)
17. Z Namiot J Sarosiek M Marcinkiewicz MC Edmunds RW [tmp] McCallum 1994 Declined human esophageal mucin secretion in patients with severe reflux esophagitis Dig Dis Sci 39 2523 2529 10.1007/BF02087685 PMID: 7995174
18. TR Demeester LF Johnson GJ Joseph MS Toscano AW Hall DB Skinner 1976 Patterns of gastroesophageal reflux in health and disease Ann Surg 184 459 470 10.1097/00000658-197610000-00009 PMID: 13747
19. BI Hirschowitz 1991 A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis Gastroenterology 101 1149 1158 PMID: 1936784.
20. V Walker WH Taylor 1980 Pepsin 1 secretion in chronic peptic ulceration Gut 21 766 771 10.1136/gut.21.9.766 PMID: 6776016
21. M Mantle A Allen 1978 A colorimetric assay for glycoproteins based on the periodic acid/Schiff stain Biochem Soc Trans 6 607 609 PMID: 208893
22. T Jaworski I Sarosiek S Sostarich, et al. 2005 Restorative impact of rabeprazole on gastric mucus and mucin production impairment during naproxen administration: its potential clinical significance Dig Dis Sci 50 357 365 10.1007/s10620-005-1611-3 PMID: 15745101 (Pubitemid 40311548)
23. T Skoczylas I Sarosiek S Sostarich C [tmp] McElhinney S Durham J Sarosiek 2003 Significant enhancement of gastric mucin content after rabeprazole administration: its potential clinical significance in acid-related disorders Dig Dis Sci 48 322 328 10.1023/A:1021983611768 PMID: 12643610 (Pubitemid 36232999)
24. J Sarosiek RM Rourk R Piascik Z Namiot DP Hetzel RW [tmp] McCallum 1994 The effect of esophageal mechanical and chemical stimuli on salivary mucin secretion in healthy individuals Am J Med Sci 308 23 31 10.1097/00000441- 199407000-00006 PMID: 8010333
25. Takiuchi H, Asada S, Umegaki E, Tahashi Y, Ohshiba S. Effects of proton pump inhibitors: omeprazole, lansoprazole and E-3810 on the gastric mucin. In: Proc. 10th World Congress of Gastroenterol, Los Angeles, CA; 1994;1404P. [PMID: 1629582].
26. M Van der Sluis BA De Koning AC De Bruijn, et al. 2006 Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection Gastroenterol 131 117 129 10.1053/j.gastro.2006.04.020 PMID: 16831596 (Pubitemid 44015753)